ISRCTN13615940终止未知
Safety and performance of FibroFix™ Cartilage P Implant and Drill Set for articular cartilage repair within the knee joint
Orthox (United Kingdom)0 个研究点目标入组 2 人开始时间: 2022年11月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 终止
- 发起方
- 入组人数
- 2
研究概览
简要总结
2024 Funder report results see attached file ISRCTN13615940_FunderReport_13Sep24.pdf (added 16/09/2024)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Patient is able to provide written informed consent
- •2. Age =18 years at the time of enrolment
- •3. Able to comply with the protocol-defined pre-operative procedures, the post-operative clinical and imaging evaluations, and the recommended rehabilitation regimen as determined by the Investigator
- •4. Has a joint surface lesion, International Cartilage Repair Society (ICRS) Grade 3 or above, on femoral condyles
- •5. Female subjects of child-bearing potential: a negative urine pregnancy test at the time of enrolment
- •6. Patient has been diagnosed by MRI or other imaging technique to confirm the presence of a cartilage lesion and the lesion remains symptomatic. Only patients for whom the decision to perform the surgery has already been made will be invited to participate. Asymptomatic lesions will NOT be included.
- •Intra-operative inclusion criterion:
- •7. Lesion area of less than 26.6 mm in height and less than 20.0 mm in width in the index knee after debridement
排除标准
- •1. Age >65 years or <18 years at the time of enrolment
- •2. Body mass index (BMI) >35 kg/m²
- •3. Lesion area of more than 26.6 mm length and more than 20.0 mm width in the index knee after debridement
- •4. Patient has multiple lesions to be treated
- •5. Articular cartilage lesions in the tibia or patella, ICRS grades 3 and above
- •6. KOOS Pain Subscale score at baseline that is <20 or >65 (scale range: maximum pain = 0, pain free = 100)
- •7. Patient has previously received the FibroFix™ Cartilage P implant
- •8. Patient suffers from any medical condition that would hinder cartilage repair, such as additional unresolved comorbidities related to the index knee
- •8.1. Clinically significant untreated ligament instability of the same knee
- •8.2. Patient is post-op from surgery on the same knee within 6 months which stipulates ongoing rehabilitation
- •8.3. Untreated, symptomatic, unstable meniscal lesions on patients with residual meniscus volume of <50% in the same compartment
- •8.4. Joint malalignment that in the opinion of the treating surgeon, requires osteotomy to correct
- •8.5. Any previous surgical cartilage treatment in the index knee within the previous 6 months
- •8.6. Evidence of osteonecrosis of the involved knee
- •9. A known allergy to:
- •9.1. General and/or regional anaesthetic
- •9.2.. Silk or silk-containing products, or
- •9.3. Glycerol or products containing glycerol
- •10. Demonstrating an active local or systemic infection
- •11. Any condition, which in the judgment of the Investigator would preclude adequate evaluation of the FibroFix™ Cartilage P implant and clinical outcome
- •12. A history of confirmed anaphylactoid reaction
- •13. Has received local administration of any type of corticosteroid or systemic administration of antineoplastic, immunostimulating, or immunosuppressive agents within 180 days prior to the scheduled surgery
- •14. Medical history that includes a confirmed diagnosis of rheumatoid or inflammatory arthritis, or relapsing polychondritis
- •15. If female and of child-bearing potential: evidence of a positive pregnancy test or a stated intention to become pregnant in the next 6 months at the time of enrolment
- •16. Currently participating in another device or drug clinical investigation or has done so in the previous 3 months which would impact the results of the surgery in the opinion of the surgeon or be a barrier to participation
研究者
相似试验
终止
不适用
FibroFix Cartilage P Knee Implant StudyOsteoarthritis, KneeNCT05560490Orthox Limited2
已完成
1 期
Safety and Efficacy Study of Fibrin Sealant (FS 4IU) for Skin Graft Fixation and Wound Healing in Subjects With Burn WoundsBurnsNCT00161759Baxter Healthcare Corporation40
终止
不适用
Initial Safety Evaluation of FibroFix™ MeniscusOther Tear of Medial Meniscus, Current InjuryNCT02205645Orthox Limited4
已完成
不适用
Determining the effectiveness of Fibrin Sealants in reducing complications in patients undergoing lateral neck dissectioCancerISRCTN99181100niversity of Liverpool51
招募中
不适用
Scaffold in Emilia Romagna and in the MAGIC NetworkCoronary Artery DiseaseNCT03327961University Hospital of Ferrara1,111